Chicago Rivet & Machine Co
Change company Symbol lookup
Select an option...
CVR Chicago Rivet & Machine Co
T AT&T Inc
HOMB Home BancShares Inc
ALG Alamo Group Inc
MGNX MacroGenics Inc
CBZ CBIZ Inc
PSEC Prospect Capital Corp
SPEC Spectralcast Inc
RC Ready Capital Corp
GNK Genco Shipping & Trading Ltd
Go

Industrials : Machinery | Small Cap Value
Company profile

Chicago Rivet & Machine Co. is engaged in the business of producing and selling rivets, cold-formed fasteners and parts, screw machine products, automatic rivet setting machines and parts and tools for such machines. The Company operates in two segments of the fastener industry: Fasteners and Assembly Equipment. The Fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners and parts, and screw machine products. The Assembly Equipment segment consists primarily of the manufacture of automatic rivet setting machines, automatic assembly equipment and parts and tools for such machines. The principal market for the Company’s products is the North American automotive industry. The Company serves various customers in the manufacture of automobiles and automotive components. The Company's wholly owned subsidiary is H & L Tool Company, Inc.

Closing Price
$26.57
Day's Change
-0.1125 (-0.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.57
Day's Low
26.50
Volume
(Light)
Volume:
465

10-day average volume:
2,234
465

Cybin to Present at the H.C. Wainwright Global Investment Conference on May 25, 2022

8:00 am ET May 11, 2022 (BusinessWire) Print

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeutics(TM)" is pleased to announce that Doug Drysdale, Cybin's Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Global Investment Hybrid Conference being held at the Fontainebleau Miami Beach May 23-26, 2022.

Mr. Drysdale's fireside chat will be webcast live on Wednesday, May 25, 2022 at 12:30 p.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company's investor relations website on the Events & Presentations page.

About Cybin

Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220511005309/en/

SOURCE: Cybin Inc.

Investors & Media: 
Leah Gibson
Vice President, Investor Relations & Strategic Communications
Cybin Inc.
leah@cybin.com
comtex tracking

COMTEX_407028547/1006/2022-05-11T08:00:04

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.